Comparative in-vitro activities of GD-40 and other beta-lactamase inhibitors against TEM-1 and SHV-2 beta-lactamases.
Danelon
G
G
Mascaretti
O
O
Radice
M
M
Power
P
P
Calcagno
M L
ML
Mata
E G
EG
Gutkind
G
G
D019818:Clavulanic Acid / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D010397:Penicillanic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D013407:Sulbactam / Q000494:pharmacology; D000078142:Tazobactam; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases
C112031:6-chloro-2-chloromethyl-2-methylpenam-3-carboxylic acid 1,1-dioxide; D004791:Enzyme Inhibitors; D065093:beta-Lactamase Inhibitors; D019818:Clavulanic Acid; C018008:brobactam; D010397:Penicillanic Acid; C062760:beta-lactamase SHV-2; D001618:beta-Lactamases; C034413:beta-lactamase TEM-1; D013407:Sulbactam; D000078142:Tazobactam